The influence of individual bone patterns on peri-implant bone loss: Preliminary report from a 3-year randomized clinical and histologic trial in patients treated with implants restored with matching-diameter abutments or the platform-switching concept

International Journal of Oral and Maxillofacial Implants

Volumn 26, Issue 3, 2011, Pages 618-630

  Canullo, Luigi ^a,b   Iannello, Giuliano ^a   Götz, Werner ^b  

^a University of Bonn ^*  (Italy)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Biglycans; Bone biomarkers; Bone level; Bone loss; Dental implants; Implant design; Platform switching; Tumor necrosis factor

Indexed keywords

BIGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ALVEOLAR BONE LOSS; ARTICLE; BONE REGENERATION; BONE REMODELING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTURE; EDENTULOUSNESS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INSTRUMENTATION; LONGITUDINAL STUDY; MALE; MANDIBLE; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TOOTH IMPLANTATION; TOOTH PROSTHESIS; TREATMENT OUTCOME;

AGED; ALVEOLAR BONE LOSS; BIGLYCAN; BONE REMODELING; DENTAL ABUTMENTS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL PROSTHESIS DESIGN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAW, EDENTULOUS, PARTIALLY; LONGITUDINAL STUDIES; MALE; MANDIBLE; MIDDLE AGED; OSSEOINTEGRATION; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863928824     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Cardaropoli G, Lekholm U, Wennstrom JL. Tissue alterations at implant-supported single-tooth replacements: A 1-year prospective clinical study. Clin Oral Implants Res 2006;17:165-171.
2. Manz MC. Factors associated with radiographic vertical bone loss around implants placed in a clinical study. Ann Periodontol 2000;5:137-151.
3. Broggini N, McManus LM, Hermann JS, et al. Persistent acute inflammation at the implant-abutment interface. J Dent Res 2003;82:232-237.
4. Broggini N, McManus LM, Hermann JS, et al. Peri-implant inflammation defined by the implant-abutment interface. J Dent Res 2006;85:473-478.
5. Hermann JS, Buser D, Schenk RK, Higginbottom FL, Cochran DL. Crestal bone changes around titanium implant. A physiologically formed and stable dimension over time. Clin Oral Implants Res 2000;11:1-11.
6. Lazzara RJ, Porter SS. Platform switching: A new concept in implant dentistry for controlling postrestorative crestal bone levels. Int J Periodontics Restorative Dent 2006;26:9-17.
7. Luongo R, Traini T, Guidone PC, Bianco G, Cocchetto R, Celletti R. Hard and soft tissue responses to the platformswitching technique. Int J Periodontics Restorative Dent 2008;28:551-557.
8. Cochran DL, Bosshardt DD, Grize L, et al. Bone response to loaded implants with non-matching implant-abutment diameters in the canine mandible. J Periodontol 2009;80:609-617.
9. Becker J, Ferrari D, Herten M, Kirsch A, Schaer A, Schwarz F. Influence of platform switching on crestal bone changes at non-submerged titanium implants: A histomorphometrical study in dogs. J Clin Periodontol 2007;34:1089-1096.
10. Jung RE, Jones AA, Higginbottom FL, et al. The influence of non-matching implant and abutment diameters on radiographic crestal bone levels in dogs. J Periodontol 2008;79:260-270.
11. Canullo L, Rasperini G. Preservation of peri-implant soft and hard tissues using platform switching of implants placed in immediate extraction sockets: A proof-of-concept study with 12- to 36-month follow-up. Int J Oral Maxillofac Implants 2007;22:995-1000.
12. Canullo L, Goglia G, Iurlaro G, Iannello G. Short-term bone level observations associated with platform switching in immediately placed and restored single maxillary implants: a preliminary report. Int J Prosthodont 2009;22:277-282.
13. Canullo L, Iurlaro G, Iannello G. Double-blind randomized controlled trial study on post-extraction immediately restored implants using the switching platform concept:Soft tissue response. Preliminary report. Clin Oral Implants Res 2009;20:414-420.
14. Calvo-Guirado JL, Ortiz-Ruiz AJ, López-Marí L, Delgado-Ruiz R, Maté-Sánchez J, Bravo Gonzalez LA. Immediate maxillary restoration of single-tooth implants using platform switching for crestal bone preservation: A 12-month study. Int J Oral Maxillofac Implants 2009;24:275-281.
15. Cappiello M, Luongo R, Di Iorio D, Bugea C, Cocchetto R, Celletti R. Evaluation of peri-implant bone loss around platform-switched implants. Int Periodontics Restorative Dent 2008;28:347-355.
16. Vela-Nebot X, Rodríguez-Ciurana X, Rodado-Alonso C, Segalà-Torres M. Benefits of an implant platform modification technique to reduce crestal bone resorption. Implant Dent 2006;15:313-320.
17. Canullo L, Rossi-Fedele G, Iannello G, Jepsen S. Platform switching and marginal bone-level alterations: The results of a randomized-controlled trial. Clin Oral Implants Res 2010;21:115-121.
18. Gargiulo AW, Wentz FM, Orban B. Dimensions and relations of the dentogingival junction in humans. J Periodontol 1961;32:261-267.
19. Lindhe J, Karring T, Lang NP. Clinical Periodontology and Implant Dentistry. Oxford: Blackwell Munksgaard, 2003.
20. Hermann F, Lerner H, Palti A. Factors influencing the preservation of the periimplant marginal bone. Implant Dent 2007;16:165-175.
21. Alsaadi G, Quirynen M, Komárek A, van Steenberghe D. Impact of local and systemic factors on the incidence of late oral implant loss. Clin Oral Implants Res 2008;19:670-676.
22. Misch CE (ed). Contemporary Implant Dentistry, ed 3. St Louis:Mosby-Elsevier, 2008.
23. Licata A. Bone density vs bone quality: What’s a clinician to do? Cleve Clin J Med 2009;76:331-336.
24. Hernandez CJ, Keaveny TM. A biomechanical perspective on bone quality. Bone 2006;39:1173-1181.
25. Brouxsein ML. Bone quality: Where do we go from here? Osteoporos Int 2003;14(suppl 5):S118-S127.
26. Watzek G (ed). Implants in Qualitatively Compromised Bone. London: Quintessence, 2004.
27. Reinhardt RA, Sanderfer VJ, Meinberg TA, Nummikowski P, Lee H-M, Marx DB. Local biochemical markers of bone turnover:Relationship to subsequent density of healing alveolar bone defects. J Clin Periodontol 2004;31:223-228.
28. Gapski R, Satheesh K, Cobb CM. Histomorphometric analysis of bone density in the maxillary tuberosity of cadavers: A pilot study. J Periodontol 2006;77:1085-1090.
29. Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants 2005;20:569-577.
30. Taba M Jr, Kinney J, Kim AS, Giannobile WV. Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am 2005;49:551-571.
31. Götz W, Gerber T, Michel B, Lossdörfer S, Henkel KO, Heinemann F. Immunohistochemical characterization of nanocrystalline hydroxyapatite silica gel (NanoBone) osteogenesis: A study on biopsies from human jaws. Clin Oral Implants Res 2008;19:1016-1026.
32. Yoshihara A, Deguchi T, Hanada N, Miyazaki H. Relation of bone turnover markers to periodontal disease and jaw bone morphology in elderly Japanese subjects. Oral Dis 2009;15:176-181.
33. Moheng P, Feryn JM. Clinical and biologic factors related to oral implant failure: A 2-year follow-up study. Implant Dent 2005;14:281-288.
34. Sharma CG, Pradeep AR. Gingival crevicular fluid osteopontin levels in periodontal health and disease. J Periodontol 2006;77:1674-1680.
35. Kivelä-Rajamäki MJ, Teronen OP, Maisi P, et al. Laminin-5 gamma2-chain and collagenase-2 (MMP-8) in human periimplant sulcular fluid. Clin Oral Implants Res 2003;14:158-165.
36. Monov G, Strbac GD, Baron M, Kandler B, Watzek G, Gruber R. Soluble RANKL in crevicular fluid of dental implants: A pilot study. Clin Implant Dent Relat Res 2006;8:135-141.
37. Aksoy U, Eratalay K, Tözüm TF. The possible association among bone density values, resonance frequency measurements, tactile sense, and histomorphometric evaluations of dental implant osteotomy sites: A preliminary study. Implant Dent 2009;18:316-325.
38. McKee MD, Addison WN, Kaartinen MT. Hierarchies of extracellular matrix and mineral organization of bone of the craniofacial complex and skeleton. Cells Tissue Organs 2005;181:176-188.
39. Bonucci E, Nanci A. Alkaline phosphatase and tartrate-resistant acid phosphatase in osteoblasts of normal and pathologic bone. Ital J Anat Embryol 2001;106(suppl 1):129-133.
40. Doglioli P, Scortecci G. Characterization of endosteal osteoblasts isolated from human maxilla and mandible: An experimental system for biocompatibility tests. Cytotechnology 1991;7:39-48.
41. Clausen C, Hermund NU, Donatsky O, Nielsen H, Osther K. Homologous activated platelets stimulate differentiation and proliferation of primary human bone cells. Cells Tissues Organs 2006;184:68-75.
42. Yefang Z, Hutmacher DW, Varawan SL, Meng LT. Comparison of human alveolar osteoblasts cultured on polymer-ceramic composite scaffolds and tissue culture plates. Int J Oral Maxillofac Surg 2007;36:137-145.
43. Schroeder TM, Jensen ED, Westendorf JJ. Runx2: A master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 2005;75:213-225.
44. Goldring SR. Inflammatory mediators as essential elements in bone remodeling. Clacif Tissue Int 2003;73:97-100.
45. Taubman MA, Valverde P, Han X, Kawai T. Immune response:The key to bone resorption in periodontal disease. J Periodontol 2005;76(suppl):2044-2041.
46. Wong PKK, Christie JJ, Wark JD. The effects of smoking on bone health. Clin Sci 2007;113:233-241.
47. Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone remodeling and remodeling. Arch Biochem Biophys 2008;473:139-146.
48. Anandarajah AP. Role of RANKL in bone diseases. Trans Endocrinol Metabol 2009;20:88-94.
49. Leibbrandt A, Penninger JM. RANK/RANKL: Regulators of immune responses and bone physiology. Ann NY Acad Sci 2008;1143:123-150.
50. Mueller RJ, Richards RG. Immunohistological identification of receptor activator of NF-kappaB ligand (RANKL) in human, bovine and bovine bone tissues. J Mater Sci Mater Med 2004;15:367-372.
51. Derner R, Anderson AC. The bone morphogenetic protein. Clin Pod Med Surg 2005;22:607-618.
52. Dai J, Rabie ABM. VEGF: An essential mediator of both angiogenesis and enchondral ossification. J Dent Res 2007;86:937-950.
53. Tanaka S, Matsuzaka K, Sato D, Inoue T. Characteristics of newly formed bone during guided bone regeneration:Analysis of CBFA-1, osteocalcin, and VEGF expression. J Oral Implantol 2007;33:321-326.
54. Cornelini R, Artese L, Rubini C, et al. Vascular endothelial growth factor and microvessel density around healthy and failing implants. Int J Oral Maxillofac Implants 2001;16:389-393.
55. Waddington RJ, Roberts HC, Sugars RV, Schönherr E. Differential role for small leucine-rich proteoglycans in bone formation. Euro Cells Mater 2003;6:12-21.
56. Schaefer L, Iozzo RV. Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction. J Biol Chem 2008;283:21305-21309.
57. Bradley JR. TNF-mediated inflammatory disease. J Pathol 2008;214:149-160.
58. Hess K, Ushmorov A, Fiedler J, Brenner RE, Wirth T. TNFα promotes osteogenic differentiation of human mesenchymal stem cells by triggering NF-;107;1B signalling pathway. Bone 2009;45:367-376.